Source: ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Milou M.F. Schuurbiers, Mariolina Bruno, Sanne M.H. Zweijpfenning, Cecile Magis-Escurra, Martin Boeree, Mihai G. Netea, Jakko van Ingen, Frank van de Veerdonk, Wouter Hoefsloot. Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis. ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020

Member's Comments

No comment yet.

Related content which might interest you: Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 A patient with cystic fibrosis and Mycobacterium abscessus infection Source: International Congress 2018 – CC1 Lung transplantation Year: 2018 Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis Source: Eur Respir J 2015; 46: 707-716 Year: 2015 Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Pulmonary aspergilloma complicated by a cavitary lesion caused by pulmonary Mycobacterium avium complex disease Source: Eur Respir J 2005; 26: Suppl. 49, 689s Year: 2005 Subtle immunodeficiencies in nodular–bronchiectatic Mycobacterium avium complex lung disease Source: ERJ Open Res, 6 (4) 00548-2020; 10.1183/23120541.00548-2020 Year: 2020 Interstitial pulmonary disease and mycobacterium interjectum Source: Eur Respir J 2006; 28: Suppl. 50, 26s Year: 2006 Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection Source: Eur Respir J 2015; 46: 1823-1826 Year: 2015 Emerging untreatable non-tuberculous pulmonary disease due to Mycobacterium abscessus Source: Eur Respir J 2004; 24: Suppl. 48, 415s Year: 2004 Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients Source: Eur Respir J 2013; 41: 1101-1106 Year: 2013 Clinical features of pulmonary Mycobacterium avium intracellulare complex disease with a solitary pulmonary nodule in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 687s Year: 2005 Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy Source: Eur Respir J 2005; 25: 324-328 Year: 2005 Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosis Source: Eur Respir J 2016; 47: 990-993 Year: 2016 Persistent non-tuberculous mycobacteria in cystic fibrosis Source: Virtual Congress 2020 – Paediatric respiratory diseases Year: 2020 Nontuberculous mycobacteria infection in patients with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 615s Year: 2004 Clinical analysis of pulmonary Mycobacterium kansasii disease Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Clinical relevance of Mycobacterium simiae in pulmonary samples Source: Eur Respir J 2008; 31: 106-109 Year: 2008 Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005 Association of bronchiectasis with mycobacteria other than tuberculosis in patients with collagen vascular disease Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002